MedPath

EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer

Recruiting
Conditions
Cancer
Interventions
Other: Dose escalated resistance training
Registration Number
NCT06083324
Lead Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Brief Summary

This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements under close supervision on individuals who have been treated for cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Age 20-89 years
  2. Women of child-bearing potential must verbally confirm lack of pregnancy prior to enrollment. They should also consent to use adequate contraception during the course of the study.
  3. Participants must be determined capable of engaging in resistance training by exercise personnel and/or study PI
  4. Participants must complete an assessment by EOC staff and be determined safe to engage in the workout regimen by the study exercise personnel.
  5. Individuals not deemed safe to participate in the standard EOC exercise program will be referred to physical therapy or elsewhere
Exclusion Criteria
  1. Severe arthritic, joint, cardiovascular, or musculoskeletal condition that would interfere with exercise program

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Colorectal cancer patientsDose escalated resistance trainingAll patients undergoing treatment for colorectal cancer on an exercise regime
Pancreatic cancer patientsDose escalated resistance trainingAll patients undergoing treatment for pancreatic cancer on an exercise regime
Metastatic breast cancer patientsDose escalated resistance trainingAll patients undergoing treatment for metastatic breast cancer on an exercise regime
General cancer patientsDose escalated resistance trainingAll patients undergoing treatment for cancer on an exercise regimen
Head and neck cancer patientsDose escalated resistance trainingAll patients undergoing treatment for head and neck cancer on an exercise regime
Primary Outcome Measures
NameTimeMethod
Determine changes in muscle mass in pounds from before to after the nutrition and exercise regimen3 months

Measurement on bioimpedance analysis machine (Inbody 970)

Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via bioimpedance analysis3 months

Measurement on bioimpedance analysis machine (Inbody 970)

Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via ultrasound3 months

Measurement via ultrasound and calculation with Jackson-Pollack calculations

Secondary Outcome Measures
NameTimeMethod
Determine changes in overall score of functional movement screen (FMS) from before to after the nutrition and exercise regimen3 months

Determine changes in overall score of functional movement screen (FMS) from before to after the nutrition and exercise regimen

Determine changes in strength via load measured in pounds from before to after the nutrition and exercise regimen3 months

Load is calculated by multiplying sets by repetitions by weight lifted for a specific exercise

Determine changes in Y-balance score for each leg3 months

Y-balance score adds up the distance each leg can move in the front and side directions, divided by the length of the hip. This correlates inversely with fall risk.

Determine changes in EQ-5D responses 1-5 and overall score from before to after the nutrition and exercise regimen3 months

EQ-5D asks 5 questions rates from 1-5 and an overall rating of health

Trial Locations

Locations (1)

AHN CI Exercise Oncology and Resiliency Center

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath